The effect of strain differences on the assay of rabies virus glycoprotein by single radial immunodiffusion.
Antigenic differences between rabies virus strains used for vaccine manufacture can be demonstrated using monoclonal antibodies. We have shown that these differences are sufficiently large to affect the potency values of vaccines measured in single radial immunodiffusion (SRD) assays if the reference and test vaccines are antigenically heterologous. The production of reagents for use in SRD assays for each strain of rabies virus should be considered.
D000818:Animals; D006023:Glycoproteins / Q000276:immunology*; D005779:Immunodiffusion; D051379:Mice; D011819:Rabies Vaccines / Q000276:immunology*; D011820:Rabies virus / Q000276:immunology*; D013045:Species Specificity; D014764:Viral Proteins / Q000276:immunology*
D006023:Glycoproteins; D011819:Rabies Vaccines; D014764:Viral Proteins